Key Segments:
By Component
-
RFID Tags
-
RFID Readers
-
RFID Middleware
-
Software & Services
By Type
-
Chipped RFID
-
Chipless RFID
By Application
-
Drug Tracing & Authentication
-
Drug Quality & Condition Monitoring
-
Inventory & Supply Chain Management
-
Anti-Counterfeiting
By End User
-
Drug Manufacturers
-
Hospital & Clinical Pharmacies
-
Retail & E-Pharmacies
-
Distributors & Wholesalers
Regional Coverage:
North America
-
US
-
Canada
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Component X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players in the North America RFID in Pharmaceuticals Market include Avery Dennison Corporation, Zebra Technologies Corporation, Impinj, Inc., CCL Industries Inc., and Fresenius Kabi AG, among others.
Key opportunities include automated bulk verification at distribution and returns points, sensor-enabled cold-chain monitoring, and expanding chipless tag adoption across the region.
The market is driven by DSCSA serialization enforcement, expanding biologics manufacturing, and growing hospital and retail pharmacy automation across the region.
The RFID Tags segment dominated the North America RFID in Pharmaceuticals Market, accounting for approximately 46.20% share in 2025.
The U.S. dominated the North America RFID in Pharmaceuticals Market in 2025 with an 88.90% share, driven by its large pharmaceutical manufacturing base and DSCSA enforcement pressure.
